Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector.
Brenner
M K
MK
Center for Cell and Gene Therapy, Houston, Texas 77030-2399, USA.
Heslop
H
H
Krance
R
R
Horowitz
M
M
Strother
D
D
Nuchtern
J
J
Grilley
B
B
Martingano
E
E
Cooper
K
K
D000256:Adenoviridae / Q000235:genetics*; D000293:Adolescent; D000328:Adult; D019744:Chemokines, C; D002648:Child; D002675:Child, Preschool; D005260:Female; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D006801:Humans; D007167:Immunotherapy; D007223:Infant; D007376:Interleukin-2 / Q000235:genetics*; D008222:Lymphokines / Q000235:genetics*; D008297:Male; D009447:Neuroblastoma / Q000235:genetics* / Q000628:therapy*; D012008:Recurrence; D012795:Sialoglycoproteins / Q000235:genetics*; D014161:Transduction, Genetic; D014407:Tumor Cells, Cultured
D019744:Chemokines, C; D007376:Interleukin-2; D008222:Lymphokines; D012795:Sialoglycoproteins; C092390:XCL1 protein, human; C018997:lymphotactin